Increased APL reactivity has been found in both relapsing-remitting and secondary-progressive MS compared to healthy controls with the highest APL positive rate (> 50%) during the clinical exacerbations and with its decrease a few months after relapse (132). Here, FASLG is linked to myeloid sarcoma.